Delivery Order SPE2DX22D0089-SPE2D826F0B71
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $6,565.18 to AmerisourceBergen Drug Corp on October 1, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price, non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026. The contract is being performed at AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $29,247.48 to AmerisourceBergen Drug Corp on October 13, 2025, with an ultimate completion date of October 14, 2025. This non-set-aside, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a firm fixed-price delivery order valued at $65,553.00 to AmerisourceBergen Drug Corp on October 3, 2025. This non-competitive delivery order, which serves as a child contract to a larger vehicle, leverages AmerisourceBergen's extensive pharmaceutical distribution capabilities to support federal medical procurement needs. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $11,439.51 to AmerisourceBergen Drug Corp on August 26, 2025, with completion scheduled for August 27, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract covers pharmaceutical and medical supply...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $63,651.60 to AmerisourceBergen Drug Corp on October 13, 2025, with an ultimate completion date of October 14, 2025. This firm fixed-price delivery order, issued under a competitive process with no set-aside designation, represents a child contract under AmerisourceBergen's larger pharmaceutical prime vendor agreement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $108,554.87 to AmerisourceBergen Drug Corp on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract for pharmaceutical products and medical supplies. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $46,349.46 to AmerisourceBergen Drug Corp on September 29, 2025, with completion scheduled for September 30, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be performed at the...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 2, 2025, for pharmaceutical products and medical supplies with a ceiling value of $59,150.00. This competitively awarded, firm fixed-price delivery order is set to conclude on October 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $5,986.23 to AmerisourceBergen Drug Corp on October 1, 2025, with an ultimate completion date of the same date. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,790.80 to AmerisourceBergen Drug Corp on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside...
- SPE2DX22D0089Indefinite Delivery Contract
- SPE2DX22D0089-SPE2D826F0B71Delivery Order
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $56,624.80 to AmerisourceBergen Drug Corp on October 13, 2025, with an ultimate completion date of October 14, 2025. This is a firm fixed-price, non-set-aside delivery order issued under contract number 4569742683. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order represents a child contract under the company's broader relationship with DLA procurement. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs worldwide. The contract demonstrates the company's extensive capability to meet federal medical supply requirements through competitive procurement, with delivery performance at the specified place of performance in Conshohocken, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $56.6k | 10/13/25 |